Abstract
Disruption of epidermal-mesenchymal communication due to a delay in epithelialization, increases the frequency of developing fibrotic conditions in skin. As matrix metalloproteinases-2 (MMP-2) and -9 (MMP-9) are two key enzymes involved in wound healing and tissue remodeling, here we examined the efficacy of keratinocyte-fibroblast interaction on modulation of these enzymes and their inhibitors. The conditioned media derived from keratinocytes and fibroblasts grown in upper and lower chambers of a co-culture system, respectively, were analyzed for MMP-2 and -9. Keratinocyte or fibroblast conditioned medium (FCM) was used as a control. Gelatinolytic activity analyzed by zymography showed that keratinocytes mainly express MMP-9 and to a lesser extent MMP-2; while fibroblasts express only MMP-2. In a co-culture system, the activities of both MMP-2 and MMP-9 markedly increased in conditioned media collected from bottom chambers. These findings were consistent with the level of MMP-2 and MMP-9 measured by Western blot. Using the same experimental setting, the levels of tissue inhibitors of MMPs (TIMPs) secreted by keratinocytes and fibroblasts grown in the same co-culture system were also evaluated. Western blot showed that fibroblasts secrete only TIMP-1 and TIMP-2 whose levels were increased by co-culturing fibroblasts with keratinocytes. In contrary the level of TIMP-3, which was mainly expressed by keratinocytes, increased by co-culturing these cells with fibroblasts. In conclusion, interaction of fibroblast-keratinocyte modulates the levels of MMP-2 and -9 and their inhibitors produced by these cells and this interaction may be critical for a better healing quality at a late stage of the wound healing process. (Mol Cell Biochem 269: 209–216, 2005)
Similar content being viewed by others
References
Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW: Release of gelatinase A during platelet activation mediates aggregation. Nature 386: 616–619, 1997
McQuibban GA, Gong JH, Tam EM, McCulloch CA, Clark-Lewis I, Overall CM: Inflammation dampened by gelatinase. A cleavage of monocyte chemoattractant protein-3. Science 289: 1202–1206, 2000
Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R: Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101: 1833–1839, 2000
Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JRB, Sawicki G, Schulz R: Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106: 1543–1549, 2002
Gniadecki R: Regulation of keratinocyte proliferation. Gen Pharmac 30: 619–622, 1998
Lyons JG, Birkedal-Hansen B, Pierson MC, Whitelock JM, Birkedal-Hansen H: Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem. 268(25): 19143–19151, 1993
Han YP, Tuan TL, Hughes M, Wu H, Garner WL: Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem. 276: 22341–22350, 2001
Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H: Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266: 1436–1441, 1991
Bolivar-Flores J, Poumian E, Marsch-Moreno M, Montes de Oca G, Kuri-Harcuch W: Use of cultured human epidermal keratinocytes for allografting burns and conditions for temporary banking of the cultured allografts. Burns 16: 3–8, 1990
Duinslaeger L, Verbeken G, Reper P, Delaey B, Vanhalle S, Vanderkelen A: Lyophilized keratinocyte cell lysates contain multiple mitogenic activities and stimulate closure of meshed skin autograft-covered burn wounds with efficiency similar to that of fresh allogeneic keratinocyte cultures Plast Reconstr Surg 98: 110–117, 1996
Somers T, Verbeken G, Vanhalle S, Delaey B, Duinslaeger L, Govaerts P, Offeciers E: Lysates from cultured allogeneic keratinocytes stimulate wound healing after tympanoplasty. Acta Oto-Laryngologica 116: 589–593, 1996
Eisinger M, Sadan S, Silver IA, Flick RB: Growth regulation of skin cells by epidermal cell-derived factors: Implications for wound healing Proc Natl Acad Sci USA 85: 1937–1941, 1988
Silver IA, Eisinger M: Influence of an epidermal cell extract on skin healing and scar formation. Int J Tissue React 10: 381–385, 1998
Garner WL: Epidermal regulation of dermal fibroblast activity. Plast Reconstr Surg 102: 135–139, 1998
Kratz G, Jansson K, Gidlund M, Haegrerstrand A: Keratinocyte conditioned medium stimulates type IV collagenase synthesis in cultured human keratinocytes and fibroblasts. Brit J Dermatol 133: 842–846, 1995
Jaakkola P, Kontusaari S, Kauppi T, Maata A, Jalkanen M: Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes. FASEB J 12: 959–969, 1998
Kolodka TM, Galick JA, Taichman LB: Evidence for keratinocyte stem cells in vitro: Long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci USA 95: 4356–4361, 1998
Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kahari VM, Saarialho-Kere U: Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 109: 96–101, 1997
Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6: 331–343, 1975
Ghahary A, Marcoux Y, Karimi-Busheri F, Edward E. Tredget: Keratinocyte differentiation inversely regulates the expressions of involucrin and transforming growth factor beta-1. J. Cell. Biochem. 83: 239–248, 2001
Sawicki G, Sanders EJ, Salas E, Wozniak M, Rodrigo J, Radomski MW: Localization and translocation of MMP-2 during aggregation of human platelets. Thrombosis & Haemostasis 80: 836–839, 1998
Sawicki G, Matsuzaki A, Janowska-Wieczorek A: Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion. J Cancer Res Clin Oncology 124: 245–252, 1998
Nagase H, Woessner, JF Jr: Matrix metalloproteinases. J Biol Chem 274: 21494–21494, 1999
Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med. 4: 197–250, 1993
Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE: Collangenase production is lower in post-burn hypertrophic scar fibroblasts than normal fibroblasts and is down regulated by insulin-like growth factor-1. J. Invest. Dermatol 106: 476–487, 1996
Machesney M, Tidman N, Waseem A, Kirby L, Leigh I: Activated keratinocytes in the epidermis of hypertrophic scars. AM J Pathol 152: 1133–1141, 1998
Leco KJ, Khokha R, Pavloff N, Hawkes S, Edwards DR: Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 269: 9352–9360, 1994
Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knäuper V, Docherty AJP, Murphy G: TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39–44, 1998
Apte SS, Olsen BR, Murphy G: The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem. 270: 14313–14318, 1995
Greene J, Wang M, Liu YE, Raymond LA, Rosen C, Shi YE: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375–30380, 1996
Leco KJ, Apte SS, Taniguchi GT, Hawkes SP, Khokha R, Schultz GA, Edwards DR: Murine tissue inhibitor of metalloproteinases-4 (TIMP-4). cDNA isolation and expression in adult mouse tissues. FEBS Lett 401: 213–217, 1997
Liu Ye, Wang M, Greene J, Su J, Ullrich S, Li H, Sheng S, Alexander P, Sang QA, Shi YE: Preparation and characterization of recombinant tissue inhibitor of metalloproteinases (TIMP-4). J Biol Chem 272: 20479–20483, 1997
Woessner JF, Nagase H: Matrix metalloproteinases and TIMPs. Oxford University Press, Oxford, 2000
Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS: Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 10: 26–37, 2002
Angel P, Szabowski A: Function of AP-1 target genes in mesenchymal-epithelial cross-talk in skin. Biochem Pharm 64: 949–956, 2002
Ghahary A, Karimi-Busheri F, Marcoux Y, Li Y, Tredget, EE, Taghi Kilani R, Liang L, Zheng J, Karami A, Keller B, Weinfeld M: Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 122: 1188–1197, 2004
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sawicki, G., Marcoux, Y., Sarkhosh, K. et al. Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol Cell Biochem 269, 209–216 (2005). https://doi.org/10.1007/s11010-005-3178-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-3178-x